Anemia of Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Anemia of Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex) [Phase 3]
Phase 3 trial evaluating subcutaneous Eporon versus epoetin alfa for anemia of chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients [Phase 1, Phase 2]
Phase 2a study evaluating PRS-080 in anemia of chronic kidney disease completed.
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) [Phase 3]
Phase 3 long-term study of JR-131 in renal anemia patients with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Effect of Erythropoiesis-Stimulating Agent Therapy in Patients Receiving Palliative Care of Chronic Kidney Disease
This clinical trial update summarizes erythropoiesis-stimulating agent therapy in patients with anemia of chronic kidney disease in a pallia…
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients? [Phase 2]
Phase 2 clinical trial updating the potential for oral pentoxifylline to improve hemoglobin in patients with anemia of chronic kidney diseas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia [Phase 2]
Phase 2 pilot study of KRX-0502 (ferric citrate) administered without food for iron-deficiency anemia in chronic kidney disease completed.
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on Dialysis
Observational study of Mircera in CKD patients not on dialysis has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin [Phase 3]
Pfizer's Hospira conducted a Phase 3 long-term safety study of intravenous epoetin alfa in adults with chronic kidney disease requiring hemo…
-
CLINICAL_TRIALS other · 2018-06-27Clinical Trial Update: Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient [NA]
This clinical trial update notes anemia correction and Fibroblast Growth Factor 23 level assessment in chronic kidney disease and renal tran…
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Factors Influencing Hemoglobin Variability and Its Association With Mortality in Hemodialysis Patients
This completed clinical trial investigates factors that influence hemoglobin variability in hemodialysis patients and examines its associati…
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD [Phase 3]
Phase 3 clinical trial of ferric citrate (KRX-0502) for treating iron deficiency anemia in adults with non-dialysis-dependent chronic kidney…
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: CKD-11101 Phase 3 SC Study [Phase 3]
Phase 3 study of CKD-11101 in anemia of chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis [Phase 3]
A Phase 3 IV study in patients with anemia of chronic kidney disease on hemodialysis has completed.
-
CLINICAL_TRIALS research · 2017-10-20Clinical Trial Update: Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients [Phase 1, Phase 2]
This document reports a Phase Ib/Phase II trial evaluating PRS-080 for anemia of chronic kidney disease. The current trial status is unknown…
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Periodic Versus Continuous IV Iron Supplementation in HD Patients [Phase 4]
Phase 4 trial comparing periodic versus continuous IV iron supplementation in hemodialysis patients with anemia of chronic kidney disease ha…
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease [Phase 2]
Phase 2 trial update reporting results of a 4-week switch study in hemodialysis-dependent patients with anemia associated with chronic kidne…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis [Phase 3]
Phase 3 trial of roxadustat (FG-4592) for anemia in chronic kidney disease not on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease [Phase 2]
Phase 2 trial evaluating whether vitamin D modulates serum hepcidin in children with anemia of chronic kidney disease; results have been pos…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment [Phase 1]
A Phase 1 study comparing intravenous epoetin alfa products from Hospira and Amgen in chronic kidney disease patients on hemodialysis receiv…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Efficacy Study of Two Formulations of Erythropoietin [Phase 3]
A Phase 3 efficacy trial comparing two formulations of epoetin in patients undergoing hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia [Phase 2]
Phase 2 dose‑response study evaluating the safety and efficacy of GSK1278863 (daprodustat) for anemia in hemodialysis-dependent patients wit…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia [Phase 2]
Phase 2 trial update showing results for intravenous Mircera in hemodialysis patients with anemia due to chronic kidney disease; results pos…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis [Phase 1]
A Phase 1 mass balance study evaluating JTZ-951 in subjects with end-stage renal disease on hemodialysis has been completed, in the context …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia. [Phase 3]
Phase 3 trial comparing Mircera given every four weeks to epoetin beta in dialysis patients with anemia due to chronic kidney disease, asses…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients [Phase 3]
Phase 3 trial evaluating intravenous or subcutaneous Mircera for anemia in dialysis patients has completed; this entry provides a trial resu…